Conclusions
MM
MULTIPLE MYELOMA, DISEASE, IMMUNE DEFICIENCY
For the elderly NDMM, the CEMM2021 algorithm in our center might provide a valuable reference for the guidance of therapeutic strategies, with the combination of Bregs resulting in an effective and clinically meaningful prediction in contemporary treatment.The management of elderly patients with MM remains challenging due to the heterogeneity of disease conditions, especially immune deficiency. In order to provide more evidence‐based practice for the elderly MM, the study established and assessed a stratified therapeutic model with studies on Regulatory B cells for Chinese Elderly Multiple Myeloma in 2021 (CEMM2021).
